The EU began distributing the Pfizer-BioNTech coronavirus vaccine on Saturday after approving the drug for its 27 member states last week. The mass vaccination program follows earlier approvals in the UK and US, where distribution began this month. The EU has ordered 300M doses of the vaccine to date, enough for 150M people (given the Pfizer-BioNTech vaccine requires two doses).
Extra: EU officials are expected to meet in January to consider approving Moderna’s vaccine (which was approved by US regulators last week).
The New Paper
This story is from the December 28, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
